Application 209165
- Type
- ANDA
- Sponsor
- ALEMBIC PHARMS LTD
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | DOXYCYCLINE | DOXYCYCLINE | CAPSULE;ORAL | EQ 75MG BASE | No | No |
| 002 | DOXYCYCLINE | DOXYCYCLINE | CAPSULE;ORAL | EQ 100MG BASE | No | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 46708-249 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-249 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-250 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Limited | ANDA | Current |
| 46708-250 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Limited | ANDA | Current |
| 62332-249 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-249 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-249 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-249 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-249 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-250 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-250 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-250 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-250 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 62332-250 | Doxycycline | Doxycycline | Alembic Pharmaceuticals Inc. | ANDA | Current |
| 67296-1570 | Doxycycline | Doxycycline | RedPharm Drug, Inc. | ANDA | Current |
| 67296-1570 | Doxycycline | Doxycycline | RedPharm Drug, Inc. | ANDA | Current |
| 67296-1570 | Doxycycline | Doxycycline | RedPharm Drug, Inc. | ANDA | Current |